Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists

Brain Research Bulletin
John A Gray, Bryan L Roth


5-Hydroxytryptamine(2A) (serotonin(2A), 5-HT(2A)) receptors are important for many physiologic processes including platelet aggregation, smooth muscle contraction, and the modulation of mood and perception. A large number of pharmaceutical agents mediate their actions, at least in part, by modulating the number and/or activity of 5-HT(2A) receptors. Drugs with action at 5-HT(2A) receptors are used in the treatment of many disorders, including schizophrenia, depression, and anxiety disorders. This review summarizes over two decades of research on the regulation of 5-HT(2A) receptors and provides a comprehensive review of numerous in vivo studies describing the paradoxical phenomenon of 5-HT(2A) receptor down-regulation by chronic treatment with antidepressants and antipsychotics. In addition, studies reporting antagonist-induced internalization of 5-HT(2A) receptors and other G protein-coupled receptors will be highlighted as a possible mechanism to explain this paradoxical down-regulation. Finally, a review of the cellular and molecular mechanisms that may be responsible for agonist-mediated desensitization and internalization of 5-HT(2A) receptors will be presented.


Jun 19, 1991·European Journal of Pharmacology·Bryan L Roth, R D Ciaranello
Apr 12, 1989·European Journal of Pharmacology·Josée E LeysenC J Niemegeers
Dec 3, 1985·European Journal of Pharmacology·F KoshikawaJ D Stephenson
Jan 13, 1986·Life Sciences·C A Stockmeier, K J Kellar
Jan 1, 1988·Life Sciences·N S BuckholtzD X Freedman
Mar 12, 1985·European Journal of Pharmacology·N S BuckholtzL D Middaugh
Jan 25, 1980·European Journal of Pharmacology·A MaggiS J Enna
Sep 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M A BlackshearE Sanders-Bush
Sep 1, 1982·The American Journal of Psychiatry·R E Becker, R L Dufresne
May 6, 1983·European Journal of Pharmacology·G P ReynoldsC D Marsden
Mar 3, 1995·The Journal of Biological Chemistry·V Vouret-CraviariE Van Obberghen-Schilling
Oct 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M KuoppamäkiE Syvälahti
Jan 1, 1996·Behavioural Brain Research·M Toth
Jan 1, 1996·Behavioural Brain Research·R C Ferry, P B Molinoff
Dec 1, 1995·Canadian Journal of Physiology and Pharmacology·R Rahimian, P D Hrdina
Nov 1, 1996·Trends in Pharmacological Sciences·T T ChuangA De Blasi
Aug 1, 1997·Trends in Pharmacological Sciences·J A Koenig, J M Edwardson
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R L Jakab, P S Goldman-Rakic
Apr 18, 1998·The Journal of Biological Chemistry·A W GagnonJ L Benovic
May 19, 1998·Life Sciences·Stephen S G FergusonM G Caron
Aug 26, 1998·Drug and Alcohol Dependence·Bryan L RothWesley K Kroeze
Oct 13, 1998·Pharmacology, Biochemistry, and Behavior·R L SmithE Sanders-Bush
Feb 3, 1999·Annals of the New York Academy of Sciences·D L WillinsBryan L Roth
May 29, 1999·Critical Reviews in Neurobiology·Bryan L RothK Kristiansen
Oct 3, 1999·The Journal of Biological Chemistry·R JockersS Marullo
Jun 14, 2000·Current Opinion in Neurobiology·P Tsao, Mark von Zastrow


Jul 19, 2006·Psychopharmacology·Ronald L Cowan
Feb 23, 2011·Psychopharmacology·John P Dougherty, Vincent J Aloyo
Apr 18, 2013·Experimental Brain Research·Cristiano Bombardi, Giuseppe Di Giovanni
Feb 18, 2009·Journal of Neural Transmission·Dubravka HranilovićLipa Cicin-Sain
Apr 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·F M M A van der HeijdenW M A Verhoeven
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Mar 26, 2003·Life Sciences·Dirk Van OekelenJosée E Leysen
Jul 18, 2009·Nature Reviews. Drug Discovery·Terry Kenakin
Jan 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cullen L SchmidLaura M Bohn
Nov 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kelly A JonesPeter Penzes
Apr 6, 2011·The Journal of Biological Chemistry·Aleksander Baldys, John R Raymond
Jul 9, 2011·The Journal of Pharmacology and Experimental Therapeutics·Prem N YadavBryan L Roth
May 2, 2003·Psychosomatics·Muhammad N MomenPeter F Buckley
Jun 20, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Aaron R Best, Wade G Regehr
Jun 2, 2011·Clinical Ophthalmology·June ChenMichael R Robinson
Nov 7, 2013·Genetic Testing and Molecular Biomarkers·Julia StaekerWerner Steimer
Nov 19, 2013·Pharmacology, Biochemistry, and Behavior·Lynda Uphouse
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mihaela GinjJean Claude Reubi
Jan 10, 2016·Reproductive Toxicology·Jessica Romero-ReyesMaría Elena Ayala
Oct 12, 2010·Critical Reviews in Biochemistry and Molecular Biology·Laura M Bohn, Cullen L Schmid
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Oct 2, 2012·Pharmacology & Therapeutics·Francesc Artigas
Oct 31, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Yong Kee ChoiFrank I Tarazi
Aug 21, 2015·Behavioural Pharmacology·Lena Wischhof, Michael Koch
Jul 29, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Louise M PatersonGitte Moos Knudsen
Apr 29, 2008·Neuroscience and Biobehavioral Reviews·Andrew Holmes
Sep 19, 2015·Journal of Clinical Psychopharmacology·Jeffrey J RakofskyBoadie W Dunlop
Jun 19, 2003·British Journal of Pharmacology·Leng Hong PhengRémi Quirion
Jan 29, 2008·British Journal of Pharmacology·J LongdenS J Hill
Aug 19, 2007·British Journal of Pharmacology·Terry Kenakin
Mar 16, 2013·Journal of Experimental Zoology. Part A, Ecological Genetics and Physiology·Alexander W Frere, M Danielle McDonald
May 31, 2013·Biology of the Cell·Stefania MuzzachiLorenzo Guerra
Sep 22, 2012·British Journal of Pharmacology·Terry Kenakin
Jul 11, 2006·Brain Research·Damijana Mojca JuricMarija Carman-Krzan
Jan 31, 2006·Trends in Neurosciences·Véronique BernardBertrand Bloch
Jun 24, 2005·Pharmacology, Biochemistry, and Behavior·M M Doat-MeyerhoeferR A Rabin
Nov 11, 2008·Annals of the New York Academy of Sciences·Ronald L CowanJames M Joers
Oct 8, 2013·Biomaterials·Mohammadali TabatabaeiFrançois Lagugné-Labarthet
Jul 12, 2011·Expert Opinion on Investigational Drugs·Bjørn H EbdrupBirte Glenthøj
Jun 2, 2012·Expert Opinion on Drug Discovery·Wayne StallaertMichel Bouvier
Aug 5, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Yosuke YamawakiShigeto Yamawaki
Mar 26, 2015·Frontiers in Pharmacology·Natalia AlonsoNatalia C Fernández
Apr 9, 2015·Frontiers in Pharmacology·Bruno P Guiard, Giuseppe Di Giovanni
Jul 31, 2007·Trends in Pharmacological Sciences·Ségolène GalandrinMichel Bouvier
Jul 17, 2007·Trends in Pharmacological Sciences·Barbara Bosier, Emmanuel Hermans
Apr 15, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Antita AdriaensKathelijne Peremans
May 17, 2014·The International Journal of Neuropsychopharmacology·Hans RasmussenBirte Glenthøj
Feb 6, 2014·The International Journal of Neuropsychopharmacology·Brian DeanAndrew Gibbons
May 2, 2014·Frontiers in Pharmacology·Cristiano Bombardi
Jan 21, 2015·Trends in Biochemical Sciences·Xianjun ZhangFei Xu
Mar 28, 2006·Journal of Molecular Graphics & Modelling·Harish Dureja, Anil K Madan
Sep 6, 2008·Progress in Brain Research·Marcy J Bubar, Kathryn A Cunningham
Apr 27, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R L Carhart-Harris, Guy M Goodwin
Sep 5, 2006·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert K McNamara, Susan E Carlson
Oct 10, 2007·The Australian and New Zealand Journal of Psychiatry·Carissa M CoulstonChristopher C Tennant
Jun 10, 2017·Synapse·Yong Kee ChoiFrank I Tarazi
Jan 30, 2007·Neuroreport·Gonzalo A Carrasco, George Battaglia
Feb 22, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David ErritzoeBirte Y Glenthoj
Jul 28, 2010·Experimental Animals·Kimie NiimiChitoshi Itakura
Feb 1, 2019·Journal of Virology·Colleen L MayberryMelissa S Maginnis
Jul 8, 2009·Journal of Receptor and Signal Transduction Research·Terry Kenakin
Dec 29, 2013·The Journal of Biological Chemistry·Ebba Gregorsson LundiusPer Svenningsson
Jul 6, 2014·Molecular Pharmacology·Henry A DunnStephen S G Ferguson
Jul 3, 2015·Molecular Pharmacology·Louis M LuttrellLaura M Bohn
Jun 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jonathan D UrbanRichard B Mailman
Jan 22, 2005·The Journal of Pharmacology and Experimental Therapeutics·Ian MorecroftMargaret R MacLean
May 8, 2004·The Journal of Pharmacology and Experimental Therapeutics·Małgorzata FilipKathryn A Cunningham
Feb 21, 2004·The Journal of Pharmacology and Experimental Therapeutics·K J DamjanoskaN A Muma
Apr 28, 2005·Molecular Pharmacology·Qisheng LiuAgnes Schonbrunn
Feb 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·A Elizabeth LinderStephanie W Watts
Sep 24, 2019·Pharmacological Reports : PR·Dawid GawlińskiMałgorzata Filip
Feb 29, 2020·Journal of Psychopharmacology·Daniel RosenbaumEmma Hapke
Jan 18, 2014·Molecular Endocrinology·Louis M Luttrell
Nov 5, 2019·Frontiers in Molecular Neuroscience·Matthieu ColomLuc Zimmer
Sep 1, 2017·Journal of Psychopharmacology·R L Carhart-Harris, D J Nutt
Aug 28, 2020·Canadian Journal of Physiology and Pharmacology·Pierre E Thibeault, Rithwik Ramachrandran
Jan 1, 2015·Molecular Pharmacology·Jennifer J DoneganMilena Girotti
Oct 17, 2018·European Journal of Clinical Pharmacology·Dena FirouzabadiElham Shirazi Tehrani
Sep 26, 2003·Psychosomatic Medicine·Annique SchinsKarly Hamulyák
Oct 22, 2020·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Yuji OdagakiJesús A García-Sevilla
Jan 21, 2020·Neuropharmacology·Philippe De DeurwaerdèreGiuseppe Di Giovanni
Jan 21, 2021·International Journal of Molecular Sciences·Nakul Ravi RavalGitte Moos Knudsen

Related Concepts

Central Nervous System
Receptors, Tryptamine
Serotonin Antagonists
Receptor Down-Regulation
Serotonin Agonists
GTP-Binding Proteins
Protein Targeting
Receptor, Serotonin,5-HT2A

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here